Focused Investors LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 504,000 shares of the healthcare conglomerate's stock after acquiring an additional 90,100 shares during the period. UnitedHealth Group makes up approximately 5.1% of Focused Investors LLC's portfolio, making the stock its 8th biggest position. Focused Investors LLC owned approximately 0.06% of UnitedHealth Group worth $157,233,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the first quarter valued at about $42,000. O Brien Wealth Partners LLC raised its stake in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares in the last quarter. Finally, Kentucky Trust Co raised its stake in UnitedHealth Group by 138.5% in the first quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate's stock worth $49,000 after buying an additional 54 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Up 1.4%
Shares of UnitedHealth Group stock opened at $363.95 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company's fifty day simple moving average is $311.44 and its 200-day simple moving average is $352.42. The stock has a market capitalization of $329.62 billion, a PE ratio of 15.77, a P/E/G ratio of 2.33 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm earned $6.80 EPS. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the stock. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday. Sanford C. Bernstein upped their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Weiss Ratings restated a "sell (d+)" rating on shares of UnitedHealth Group in a report on Saturday, September 27th. KeyCorp reduced their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $365.00.
Get Our Latest Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.